Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 3/20 | 0.33 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.32 |
| ▸ | TK1 | P04183 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dectaflur SCHEMBL19356830 | 0.99 | SLC6A5 (0.34) | SLC6A5DAGLAMGLL | |
| Dectaflur SCHEMBL19356844 | 0.88 | — | — | |
| SCHEMBL6419577 | 0.83 | DNM1 (0.42) | — | |
| SCHEMBL3023386 | 0.76 | STAT3 (0.34) | — | |
| Ethylene SCHEMBL18262006 | 0.70 | STAT3 (0.33) | — | |
| Dectaflur SCHEMBL6509823 | 0.67 | DNM1 (0.65) | SLC6A5 | |
| Dectaflur SCHEMBL6509828 | 0.67 | DNM1 (0.65) | SLC6A5 | |
| Dectaflur SCHEMBL6510057 | 0.65 | DNM1 (0.62) | SLC6A5 | |
| Dectaflur SCHEMBL19356581 | 0.65 | DNM1 (0.67) | SLC6A5 | |
| Dectaflur SCHEMBL6510054 | 0.65 | DNM1 (0.62) | SLC6A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190307893-A1 | NANOVESICLES WITH PORPHYRIN-LIPID CONJUGATE CORE | UNIVERSITY HEALTH NETWORK (CA) | 2019-10-10 | — | — | US | disclosed |
| WO-2017156616-A1 | NANOVESICLES COMPRISING PORPHYRIN-LIPID CONJUGATES EXHIBITING ORDERED ASSEMBLY AND BATHOCHROMIC SHIFTS | UNIVERSITY HEALTH NETWORK (CA) | 2017-09-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190307893-A1 | NANOVESICLES WITH PORPHYRIN-LIPID CONJUGATE CORE | PHOSPHO1, PCYT1A, CLTB | SLC6A5 3006/4885DAGLA 1228/4885TK1 1134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.